Benign pharyngeal mass, tonsillitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with chronic tonsillitis, tonsillar hypertrophy, adenoid hypertrophy, and benign mass of pharynx were treated with bilateral tonsillectomy, adenoidectomy and pharyngeal benign tumor; 2. Children and adolescents aged 2-16 years were divided into children group and adults group, and the guardians of children group and patients of adult group voluntarily signed informed consent.
Exclusion criteria
Exclusion criteria: 1. craniofacial abnormalities, including cleft lip and palate or submucosal cleft palate, or any anatomical or general condition that interferes with general anesthesia or the removal of tonsils and adenoids in a standard manner; 2. serious health problems, including severe cardiopulmonary diseases (e.g., cystic fibrosis, congenital heart disease); sickle cell disease; poorly controlled asthma 1 time); epilepsy needs drug treatment; diabetes mellitus (type 1 or 2) needs drug treatment; diagnosed heart disease or pulmonary heart disease; stage II hypertension (HTN) with a history of more than 99% and / or drug treatment; mental retardation; chronic special infection (such as HIV); 3. patients with confirmed malignant tumor; 4. patients or family members request withdrawal from the study or compliance; 5. mental or behavioral disorders that require or may require the initiation of new drugs, treatments or other special treatments within 14 days after surgery; 6. confirmed genetic, craniofacial, neurological or psychiatric disorders; 7. current use of ADHD drugs, psychotropic drugs, hypnotics, hypoglycemic agents or insulin, antihypertensive drugs, growth hormone, anticonvulsant, anticoagulants, daily Oral corticosteroids; (9) participants who were considered unsuitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain feeling; | — |
Countries
China
Contacts
West China Hospital, West China Medical School, Sichuan University